Search
Patexia Research
Case number 1:21-cv-00356

Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited, et al > Documents

Date Field Doc. No.Description (Pages)
Jul 25, 2022 21 Notice Requesting Removal of Co-Counsel (1)
Docket Text: NOTICE requesting Clerk to remove Jason Z. Pesick as co-counsel. Reason for request: No Longer with Winston & Strawn LLP. (Bilson, David)
Jun 11, 2021 20 SO ORDERED (5)
Docket Text: SO ORDERED, re (18 in 1:21-cv-00356-CFC, 28 in 1:20-cv-01153-CFC, 27 in 1:20-cv-01585-CFC) STIPULATION Regarding Consolidation. These cases are consolidated for all purposes and all future filings shall be made in Lead Case No. 20-1153-CFC. Signed by Judge Colm F. Connolly on 6/10/2021. Associated Cases: 1:20-cv-01153-CFC, 1:20-cv-01585-CFC, 1:21-cv-00356-CFC(nmf)
Jun 11, 2021 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:20-cv-01153-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 20-1153-CFC ONLY. (nmf)
Jun 10, 2021 19 Proposed Order (30)
Docket Text: PROPOSED ORDER Stipulated Protective Order by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Jun 8, 2021 18 Stipulation (5)
Docket Text: STIPULATION Regarding Consolidation by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Jun 2, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [17] Joint STIPULATION TO EXTEND TIME to submit a proposed scheduling order to June 8, 2021 filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Signed by Judge Colm F. Connolly on 6/2/2021. (fms)
Jun 1, 2021 17 Stipulation to EXTEND Time (2)
Docket Text: Joint STIPULATION TO EXTEND TIME to submit a proposed scheduling order to June 8, 2021 - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Apr 28, 2021 16 SO ORDERED (4)
Docket Text: SO ORDERED, re [15] Stipulation filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Party Ohm Laboratories, Inc. terminated. Signed by Judge Colm F. Connolly on 4/28/2021. (fms)
Apr 27, 2021 15 Stipulation (4)
Docket Text: STIPULATION and [Proposed] Order Dismissing Defendant Ohm Laboratories, Inc. and Amending Caption by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Apr 26, 2021 13 Answer to Counterclaim (20)
Docket Text: ANSWER to [9] Answer to Complaint,, Counterclaim, by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc..(Dellinger, Megan)
Apr 26, 2021 14 Order (2)
Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before June 1, 2021, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 6/1/2021.) Signed by Judge Colm F. Connolly on 4/26/2021. (nmf)
Apr 12, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Bryce A. Cooper and Michael A. Meneghini for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
Apr 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Michael A. Meneghini filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited,, Ohm Laboratories, Inc., [11] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Bryce A. Cooper, Jason Z. Pesick and Sharon Lin filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited,, Ohm Laboratories, Inc. Signed by Judge Colm F. Connolly on 4/9/2021. (fms)
Apr 9, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Charles B. Klein for Ohm Laboratories, Inc., for Sun Pharmaceutical Industries Limited,, for Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Apr 8, 2021 11 Pesick Pro Hac Certification (1)
Apr 8, 2021 11 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Bryce A. Cooper, Jason Z. Pesick and Sharon Lin - filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Klein Pro Hac Certification, # (2) Cooper Pro Hac Certification, # (3) Pesick Pro Hac Certification, # (4) Lin Pro Hac Certification)(Bilson, David)
Apr 8, 2021 11 Klein Pro Hac Certification (1)
Apr 8, 2021 11 Cooper Pro Hac Certification (1)
Apr 8, 2021 11 Lin Pro Hac Certification (1)
Apr 8, 2021 12 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael A. Meneghini - filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Meneghini Pro Hac Certification)(Bilson, David)
Apr 8, 2021 12 Meneghini Pro Hac Certification (1)
Apr 5, 2021 9 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and, COUNTERCLAIM against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. by Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc., Ohm Laboratories, Inc..(Phillips, John)
Apr 5, 2021 10 Disclosure Statement (3)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Limited for Ohm Laboratories, Inc., Sun Pharmaceutical Industries, Inc.; Corporate Parent No parent corporation for Sun Pharmaceutical Industries Limited, filed by Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc.. (Phillips, John)
Mar 17, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Mar 12, 2021 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Ohm Laboratories, Inc. served on 3/12/2021, answer due 4/5/2021. (Dellinger, Megan)
Mar 12, 2021 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 3/12/2021, answer due 4/5/2021. (Dellinger, Megan)
Mar 12, 2021 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited, served on 3/12/2021, answer due 4/5/2021. (Dellinger, Megan)
Mar 9, 2021 1 Main Document (18)
Docket Text: COMPLAINT filed against Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited,, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3566884.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-4, # (2) Civil Cover Sheet)(sam)
Mar 9, 2021 5 Summons- Sun Pharmaceutical Industries (2)
Mar 9, 2021 5 Summons- Sun Pharmaceuticals Industries Limited (2)
Mar 9, 2021 5 Main Document (2)
Docket Text: Summonses Issued (please complete the top portion of the form and print out for use/service). (Attachments: # (1) Summons- Sun Pharmaceutical Industries Limited, # (2) Summons- Sun Pharmaceutical Industries)(sam)
Mar 9, 2021 4 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 2, 2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/2/2023. (sam)
Mar 9, 2021 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2 ; 9,949,998 B2 ; 10,258,637 B2 ; 10,596,120 B2. (sam)
Mar 9, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
Mar 9, 2021 1 Civil Cover Sheet (1)
Mar 9, 2021 1 Exhibit 1-4 (156)
Mar 9, 2021 1 Complaint* (1)
Menu